search
Back to results

Nonpharmacologic Pain Management in FQHC Primary Care Clinics (BeatPain Utah)

Primary Purpose

Low Back Pain, Chronic Pain

Status
Recruiting
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Brief Pain Teleconsult
Telehealth Physical Therapy
Sponsored by
University of Utah
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain focused on measuring Telehealth, Pain Management, Physical Therapy, Health Disparities

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Able to communicate in English or Spanish
  • Age between 18-70
  • Visit with an FQHC provider (in-person or via telehealth) in past 90 days
  • Back pain has been an ongoing problem for at least the past 3 months, and has been a problem on at least half the days in the past 6 months
  • Access to resources necessary to receive telehealth sessions (phone or 2-way video)

Exclusion Criteria:

  • Currently pregnant
  • Currently involved in active substance use disorder treatment (other than peer support groups, AA, etc.)
  • History of spine surgery in past 6 months
  • Has a condition restricting participation in physical activity (i.e., unable to ambulate independently (with or without assistive device) for at least 5 minutes.
  • Reason for back pain is a fracture or non-musculoskeletal condition (i.e., spinal tumor, inflammatory disorder, etc.)

Sites / Locations

  • Association of Utah Community HealthRecruiting
  • The University of Utah Healthcare SystemRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Brief Pain Teleconsult

Brief Pain Teleconsult plus Telehealth Physical Therapy

Arm Description

Participants randomized to Brief Pain Teleconsult will receive the brief teleconsult intervention in Phase 1 (1-12 weeks) Responder status to the Phase 1 treatment will be examined at the 12 week assessment. Participants determined to be non-responders will receive the Telehealth Physical Therapy intervention. Responders receive no additional treatment.

Participants randomized to Brief Pain Teleconsult plus Telehealth Physical Therapy will receive the brief teleconsult intervention in Phase 1 followed by the 10-week physical therapy intervention. No additional treatment is provided after the 12 week assessment.

Outcomes

Primary Outcome Measures

PEG-3
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact

Secondary Outcome Measures

Physical Function
The PROMIS short form 6b for physical function uses fixed items from the PROMIS physical function item bank to provide a T-score with population mean = 50 (sd=10).
Sleep Disturbance
The PROMIS short form 6a for sleep disturbance uses fixed items from the PROMIS sleep disturbance item bank to provide a T-score with population mean = 50 (sd=10).
Pain Catastrophizing
The PSC-6 is a short-form questionnaire evaluating an individual's negative cognitive-affective response to anticipated or actual pain
Pain Self-Efficacy
The PSEQ-4 is a short form questionnaire evaluating an individual's confidence in performing activities despite pain
Global Impression of Change
The single-item PGIC assesses participants' of change following treatment based on the question: "Since my treatment, my pain is…" with Likert scale response options ranging from (0) "very much worse" to (6) "very much improved".
opioid use
Prescription opioid use across the 52-week follow-up will be examined from EHR noting number of prescriptions and days of use.
PEG-3
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact

Full Information

First Posted
June 1, 2021
Last Updated
June 20, 2023
Sponsor
University of Utah
Collaborators
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT04923334
Brief Title
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
Acronym
BeatPain Utah
Official Title
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 4, 2021 (Actual)
Primary Completion Date
March 31, 2024 (Anticipated)
Study Completion Date
March 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Utah
Collaborators
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The goal of this study is to improve pain management and reduce opioid reliance for patients with chronic back pain in Utah Federally-Qualified Health Centers (FQHCs). The study compares the effectiveness of nonpharmacologic pain treatments using telehealth to overcome access barriers. We will use automated EHR reminders for electronic referral to teleconsult services. Our project tests adaptive treatments and uses a hybrid type I design - focused on effectiveness outcomes while gathering implementation data to inform future efforts to scale effective strategies.
Detailed Description
This randomized clinical trial compares the effectiveness of different strategies to provide efficacious nonpharmacologic interventions to patients with back pain seeking care in FQHCs throughout the state of Utah. The strategies evaluated are designed to overcome the barriers specific to rural and low income communities served by FQHC clinics through innovative use of telehealth resources. The randomized trial will randomize individual participants to one of two interventions strategies, one providing both a brief pain teleconsult with a 10-week telehealth physical therapy, the other uses an adaptive strategy - providing the brief pain teleconsult first, followed by the 10-week telehealth physical therapy only among those non-responsive to the brief teleconsult treatment. We will also evaluate outcomes related to the efforts to implement strategies in FQHC clinics in order to provide valuable information for future efforts to scale effective strategies into other low resource health care settings. Assessments will occur at baseline and after 12-, 26- and 52-weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Chronic Pain
Keywords
Telehealth, Pain Management, Physical Therapy, Health Disparities

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
The study design is a clinical trial testing adaptive interventions. All participants receive the Brief Pain Teleconsult in Phase I. We will randomly assign participants with 1:1 distribution to also receive 10-week Telehealth Physical Therapy during Phase I. All participants are re-assessed at 12 weeks and responder status is determined. For participants not receiving Telehealth Physical Therapy in Phase I, further treatment is based on responder status. Responders receive no further treatment. Non-responders receive the 10-week Telehealth Physical Therapy in Phase II. Participants randomized to Telehealth PT in Phase I receive no further treatment. Long-term assessments occur 26 and 52 weeks after randomization.
Masking
InvestigatorOutcomes Assessor
Masking Description
The study is outcome assessor and investigator blinded. Blinding will only be broken in emergency situations for reasons of participant safety such as a serious adverse event. If blinding is broken, either intentionally or unintentionally, the reason will be fully documented and entered on an electronic case report form. Every effort will be made to discuss the decision to break blinding with the Data Safety Monitoring Board in advance.
Allocation
Randomized
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Brief Pain Teleconsult
Arm Type
Experimental
Arm Description
Participants randomized to Brief Pain Teleconsult will receive the brief teleconsult intervention in Phase 1 (1-12 weeks) Responder status to the Phase 1 treatment will be examined at the 12 week assessment. Participants determined to be non-responders will receive the Telehealth Physical Therapy intervention. Responders receive no additional treatment.
Arm Title
Brief Pain Teleconsult plus Telehealth Physical Therapy
Arm Type
Experimental
Arm Description
Participants randomized to Brief Pain Teleconsult plus Telehealth Physical Therapy will receive the brief teleconsult intervention in Phase 1 followed by the 10-week physical therapy intervention. No additional treatment is provided after the 12 week assessment.
Intervention Type
Behavioral
Intervention Name(s)
Brief Pain Teleconsult
Intervention Description
The Brief Pain Teleconsult intervention includes 2 sessions provided by a licensed physical therapist over about 1 week. The sessions focus on pain education from a biopsychosocial perspective that is designed to address negative pain appraisals and catastrophizing thoughts, providing advice to be active and engage in exercise and physical activity, and reassurance that activity is beneficial and safe.
Intervention Type
Behavioral
Intervention Name(s)
Telehealth Physical Therapy
Intervention Description
The Telehealth Physical Therapy intervention involves weekly telehealth sessions provided over 10 weeks. Telehealth Physical Therapy is provided by a licensed physical therapist. Key components of the intervention include reinforcing biopsychosocial education messages and developing an exercise and physical activity program using cognitive behavioral principles such as goal setting and positive reinforcement. Pain coping strategies including mindful breathing and progressive relaxation techniques will be included.
Primary Outcome Measure Information:
Title
PEG-3
Description
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Physical Function
Description
The PROMIS short form 6b for physical function uses fixed items from the PROMIS physical function item bank to provide a T-score with population mean = 50 (sd=10).
Time Frame
baseline, 12-, 26- and 52-weeks
Title
Sleep Disturbance
Description
The PROMIS short form 6a for sleep disturbance uses fixed items from the PROMIS sleep disturbance item bank to provide a T-score with population mean = 50 (sd=10).
Time Frame
baseline, 12-, 26- and 52-weeks
Title
Pain Catastrophizing
Description
The PSC-6 is a short-form questionnaire evaluating an individual's negative cognitive-affective response to anticipated or actual pain
Time Frame
baseline, 12-, 26- and 52-weeks
Title
Pain Self-Efficacy
Description
The PSEQ-4 is a short form questionnaire evaluating an individual's confidence in performing activities despite pain
Time Frame
baseline, 12-, 26- and 52-weeks
Title
Global Impression of Change
Description
The single-item PGIC assesses participants' of change following treatment based on the question: "Since my treatment, my pain is…" with Likert scale response options ranging from (0) "very much worse" to (6) "very much improved".
Time Frame
baseline, 12-, 26- and 52-weeks
Title
opioid use
Description
Prescription opioid use across the 52-week follow-up will be examined from EHR noting number of prescriptions and days of use.
Time Frame
across 52 week follow-up
Title
PEG-3
Description
The PEG-3 measure includes 3 items evaluating 1) pain severity, and interference of pain with 2) enjoyment and 3) general activity. Item response options range from 0-10. The PEG-3 score is expressed as the mean of all item scores with higher scores indicating greater pain impact
Time Frame
baseline, 26- and 52-weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Able to communicate in English or Spanish Age between 18-80 Visit with an FQHC provider (in-person or via telehealth) in past 90 days Back pain has been an ongoing problem for at least the past 3 months, and has been a problem on at least half the days in the past 6 months Access to resources necessary to receive telehealth sessions (phone or 2-way video) Exclusion Criteria: Currently pregnant Currently involved in active substance use disorder treatment (other than peer support groups, AA, etc.) History of spine surgery in past 6 months Has a condition restricting participation in physical activity (i.e., unable to ambulate independently (with or without assistive device) for at least 5 minutes. Reason for back pain is a fracture or non-musculoskeletal condition (i.e., spinal tumor, inflammatory disorder, etc.)
Facility Information:
Facility Name
Association of Utah Community Health
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84106
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alan Pruhs, BS
Phone
801-716-4601
Email
alan@auch.org
Facility Name
The University of Utah Healthcare System
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84108
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Victor Solis, MS
Phone
801-587-1666
Email
victor.solis@hsc.utah.edu
First Name & Middle Initial & Last Name & Degree
Julie M Fritz, PT, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
IPD will be shared through the HEAL initiative at NIH
IPD Sharing Time Frame
Following completion of the data collection
Citations:
PubMed Identifier
36351735
Citation
Fritz JM, Del Fiol G, Gibson B, Wetter DW, Solis V, Bennett E, Thackeray A, Goode A, Lundberg K, Romero A, Ford I, Stevens L, Siaperas T, Morales J, Yack M, Greene T. BeatPain Utah: study protocol for a pragmatic randomised trial examining telehealth strategies to provide non-pharmacologic pain care for persons with chronic low back pain receiving care in federally qualified health centers. BMJ Open. 2022 Nov 9;12(11):e067732. doi: 10.1136/bmjopen-2022-067732.
Results Reference
derived

Learn more about this trial

Nonpharmacologic Pain Management in FQHC Primary Care Clinics

We'll reach out to this number within 24 hrs